Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Latest Phase 2 results (and post-hoc analysis) were positive and M1Pram demonstrated after 16 weeks of treatment: Weight loss effects: -5.5kg in people with type 1 diabetes and a body mass index greater than 30kg/m, and weight loss had not plateaued by the end of the study Good glycemic control: efficacy comparable to that obtained with the commercial reference insulin Humalog (Eli Lilly) Sparing effect on insulin consumption: prandial insulin daily dose reduced by -21% Patients satisfaction: better control of appetite expressed in patient satisfaction scoring (82.4% with M1Pram vs
It can both enhance and suppress immune responses depending on what the body needs
Dutch clinical isolates
S.WuY.JinJ
The abundance of selected transcripts was also analyzed in gene-chip experiments
US$ 27.88
US$ 29.70
US$ 25.26
US$ 20.69
US$ 20.63
